First Manhattan
ALIM

First Manhattan’s Alimera Sciences ALIM Stock Holding History

First Manhattan’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-667
Closed -$55K – 1525
2014
Q4 		$55K Hold
667
– – ﹤0.01% 964
2014
Q3 		$54K Hold
667
– – ﹤0.01% 950
2014
Q2 		$59K Buy
667
+200
+43% +$17.8K ﹤0.01% 919
2014
Q1 		$55K Buy
+467
New +$45.4K ﹤0.01% 933

Other funds holding ALIM

SM
Scale Management Foster City, California $359M AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

First Manhattan's ALIM Position: Q1 2015 in Review

First Manhattan sold out of Alimera Sciences (ALIM) in Q1 2015, closing a stake of 667 shares — an estimated $55K sold.

First Manhattan first reported a position in ALIM in Q1 2014 and held it in 4 quarters. The position peaked at $59K in Q2 2014. 64 funds tracked by Wall St. Rank hold ALIM as of Q1 2015.

  • First Manhattan reported no remaining Alimera Sciences position as of Q1 2015 after selling out during the quarter.
  • First Manhattan sold 667 Alimera Sciences shares in Q1 2015, an estimated $55K.
  • First Manhattan first reported a position in Alimera Sciences in Q1 2014 and held it in 4 quarters.
  • First Manhattan's Alimera Sciences position peaked at $59K in Q2 2014.
  • 64 funds tracked by Wall St. Rank held Alimera Sciences as of Q1 2015.

Based on First Manhattan's 13F filing for Q1 2015, filed 30 Apr 2015.